Form 4: Teradyne Exec Receives Equity Grants

Teradyne's President of Semiconductor Test, Shannon John Poulin, was granted 4,460 restricted stock units and options to purchase 3,937 shares of common stock.

Summary

• Shannon John Poulin, President of Semiconductor Test at Teradyne, Inc., received a grant of 4,460 Restricted Stock Units (RSUs) on February 4, 2026.
• Each RSU represents the right to receive one share of Common Stock and will vest in four equal annual installments beginning on February 4, 2027.
• Additionally, Poulin was granted stock options to purchase 3,937 shares of Common Stock with an exercise price of $269.07, also on February 4, 2026.
• These stock options will vest 25% per year over four years, starting on February 4, 2027, and expire on February 4, 2033.
• Poulin's total beneficial ownership of common stock following these transactions is 17,235.5779 shares, which includes 64.5779 shares acquired under the Issuer's Employee Stock Purchase Plan on December 31, 2025.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive routine disclosure, reflecting standard executive compensation practices aimed at aligning management incentives with long-term shareholder value and retaining key talent.

Positives

• The grant of RSUs and stock options aligns the executive's interests with long-term shareholder value creation.
• Equity grants serve as a retention mechanism for key management personnel.
• The Employee Stock Purchase Plan (ESPP) acquisition indicates ongoing employee investment in the company.

Negatives

• No specific negatives are reported in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance, beyond the vesting schedules of the granted equity.

Industry Context

StockSavvy.ai notes that equity grants to key executives like the President of Semiconductor Test are standard practice in the technology and semiconductor industries. These grants are designed to incentivize long-term performance and retain talent in a highly competitive sector. The vesting schedule over four years is typical for aligning executive compensation with sustained company growth and strategic objectives within the semiconductor test market.

Comparison to Industry Standards

• The structure of equity compensation, including RSUs and stock options with multi-year vesting, is consistent with executive compensation practices observed at comparable technology companies such as KLA Corporation, Applied Materials, and Lam Research. These companies also utilize similar long-term incentive plans to align executive interests with shareholder returns and ensure retention of critical leadership in the capital-intensive semiconductor equipment sector.

Stakeholder Impact

• Shareholders: The grants could lead to minor dilution upon vesting but are intended to align executive performance with shareholder interests, potentially leading to long-term value creation.
• Employees: The existence of an Employee Stock Purchase Plan (ESPP) indicates broader employee participation in company ownership.

Next Steps

• Vesting of 25% of the granted RSUs on February 4, 2027, and annually thereafter for three more years.
• Vesting of 25% of the granted stock options on February 4, 2027, and annually thereafter for three more years.

Key Dates

Keywords

Teradyne, TER, Form 4, insider transaction, restricted stock units, RSUs, stock options, equity compensation, executive compensation, semiconductor test